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Abstract
Oocyte cryopreservation is extremely beneficial for assisted reproductive technologies, the treatment of infertility and
biotechnology and offers a viable alternative to embryo freezing and ovarian grafting approaches for the generation of
embryonic stem cells and live offspring. It also offers the potential to store oocytes to rescue endangered species by somatic
cell nuclear transfer and for the generation of embryonic stem cells to study development in these species. We vitrified
mouse oocytes using a range of concentrations of trehalose (0 to 0.3 M) and demonstrated that 0.1 and 0.3 M trehalose had
similar developmental rates, which were significantly different to the 0.2 M cohort (P,0.05). As mitochondria are important
for fertilisation outcome, we observed that the clustering and distribution of mitochondria of the 0.2 M cohort were more
affected by vitifrication than the other groups. Nevertheless, all 3 cohorts were able to develop to blastocyst, following in
vitro fertilisation, although developmental rates were better for the 0.1 and 0.3 M cohorts than the 0.2 M cohort (P,0.05).
Whilst blastocysts gave rise to embryonic stem-like cells, it was apparent from immunocytochemistry and RT-PCR that these
cells did not demonstrate true pluripotency and exhibited abnormal karyotypes. However, they gave rise to teratomas
following injection into SCID mice and differentiated into cells of each of the germinal layers following in vitro
differentiation. The transfer of 2-cell embryos from the 0.1 and 0.3 M cohorts resulted in the birth of live offspring that had
normal karyotypes (9/10). When 2-cell embryos from vitrified oocytes underwent vitrification, and were thawed and
transferred, live offspring were obtained that exhibited normal karyotypes, with the exception of one offspring who was
larger and died at 7 months. We conclude that these studies highlight the importance of the endometrial environment for
the maintenance of genetic stability and thus the propagation of specific genetic traits.
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Introduction
Oocyte cryopreservation offers a number of potential benefits
for assisted reproductive technologies, the treatment of infertility
and biotechnology. For example, it reduces the necessity for
women undergoing chemotherapy to have to rely on the highly
invasive approach of ovarian freezing and subsequent grafting to
rescue oocytes [1]. It also reduces the need for women to undergo
repeated hyper-stimulation protocols as oocytes, rather than
embryos, could be stored [2]. Furthermore, oocyte cryopreserva-
tion is particularly attractive for women in countries where
embryo freezing is restricted through legislation and emphasis lies
on gamete freezing [3].
Cryopreservation also offers the opportunity to store oocytes
from endangered species that can then be either fertilised with
fresh or cryopreserved sperm from the same species or sub-species
or used as recipients for somatic cell nuclear transfer (SCNT) to
propagate the desired genetic material [4]. The resultant embryos
could then be transferred to the mother or a surrogate to produce
live offspring or cultured in vitro to derive embryonic stem (ES)
cells. Characteristically, ES cells derived from the same embryo
are genetically identical and self-renew [5]. They are also
pluripotent in nature, which confers the potential to differentiate
into all cell types of the body and provides an excellent resource
for studying cellular differentiation and development, especially
when the gametes used to generate these cells are from near
extinct or endangered species.
Nevertheless, the reestablishment of a species is often dependent
on the use of a somatic cell transferred into the enucleated oocyte
from a closely related species or subspecies [6]. However, a
number of genetic and epigenetic abnormalities arise from SCNT
due to the somatic nature and epigenetic memory associated with
these cells and, as a result, the process is highly reliant on the
reprogramming of the somatic cell by the recipient oocyte’s
cytoplasm [7]. The use of fertilised cryopreserved oocytes would
allay the use of this more genetically divergent approach and
promote chromosomal and mitochondrial genetic identity and
integrity. In this instance, sperm stored from the same species
would be used to fertilise cryopreserved oocytes, which would then
be cultured to the blastocyst stage from which ES cells could be
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harvested. This would provide an unlimited source of pluripotent
ES cells for subsequent rounds of nuclear transfer and would
ensure that the oocyte would not need to reprogramme the
transferred cell. In turn, this would increase nuclear transfer
outcome and reduce the number of abnormalities arising from
reprogramming. Common approaches to oocyte cryopreservation
include: i) slow-freeze and rapid thaw; and ii) rapid freezing and
warming, i.e. vitrification. Both approaches are highly dependent
upon cryoprotectant agents (CPA) that protect oocytes from
damage during the freezing process. Currently, these approaches
necessitate the injection of cryoprotectants into the oolemma [8],
laser ablation of the zona pellucida to promote sperm penetration
[9] or intracytoplasmic sperm injection [10,11]. In terms of
cryobiology, temperature changes during freezing damage the
structural integrity of the oocyte, which can result in oocyte
activation and parthenogenesis [12]. Furthermore, cryopreserva-
tion can lead to premature extrusion of corticle granules resulting
in zona hardening [13]; microtubular spindle injury [14] and
condensed chromosomes [15] resulting in, for example, atypical
haplotypes. It is likely that cryopreservation will affect mitochon-
drial integrity, which will reduce the oocyte’s stores of ATP and
affect oocyte function. Indeed, mitochondrial function is vital to
oocyte competency [16] and ATP, generated through oxidative
phosphorylation (OXPHOS) in the mitochondria, rather than
cytoplasmic glycolysis, is essential to mediate fertilisation and post-
fertilisation events and the first cell division [17]. Furthermore,
insufficient numbers of mitochondria in the metaphase II oocyte
often result in preimplantation development arrest [18]. Collec-
tively or individually, these outcomes will reduce the oocyte’s
potential to undergo and complete fertilisation and lead to
successful and normal development.
In the mouse, modified slow-freezing protocols, with increased
sucrose and the replacement of sodium with choline, have resulted
in fetal/live birth rates of up to 47.6% [9]. On the other hand,
vitrification of mouse oocytes in a G1.2 medium [19] without
NaHCO3 but supplemented with HEPES and using a nylon loop
system, resulted in fetal rates of 37.9% [20]. Although the
cryoprotective action of sucrose is well-documented, other CPAs
such as trehalose and lactose are more able to stabilise membranes
in an aqueous environment than sucrose [21] and would thus
provide post-warmed cryopreserved oocytes with minimum intra-
and extra-cellular disruption. This would most likely reduce the
need for intracytoplasmic sperm injection (ICSI) or zona ablation
following warming and promote the maintenance of the oocyte’s
structural integrity. Nevertheless, the inclusion of sucrose allows
the toxic effects of DMSO, a key CPA, to be buffered [22] thus
adding to the overall protection provided to the oocyte.
We have set out to demonstrate that oocyte vitrification using
trehalose, in combination with sucrose, is a viable alternative to
embryo freezing and ovarian grafting approaches for the generation
of ES cells and live offspring. We have demonstrated that vitrified
oocytes can be fertilized in vitro where motile sperm can penetrate
the zona pellucida and propagate syngamy, instead of relying on
invasive processes such as ICSI, injection of cryoprotectants into the
oolemma or laser ablation of the zona pellucida. We have
demonstrated that embryos obtained from vitrified oocytes were
able to generate live offspring. Similarly, when 2-cell embryos from
vitrified oocytes were subjected to a further round of vitrification,
live offspring were also obtained following warming and embryo
transfer. However, the long-term culture of ES cells derived from
vitrified oocytes suggests that they are more susceptible to abnormal
karyotypes. The latter highlights the importance of the endometrial
environment for the maintenance of genetic stability and thus the
propagation of specific genetic traits.
Results
Vitrification of oocytes
In order to derive viable ESCs from vitrified oocytes, we
generated a series of blastocysts from oocytes treated with a
sucrose-DMSO-EG-based vitrification solution containing a range
of trehalose concentrations. In this respect, oocytes were vitrified
with one of 0 (control), 0.1, 0.2 and 0.3 M trehalose concentra-
tions and following warming, they were either cultured in
fertilisation medium or fertilised with fresh epidydimal sperm
and cultured in vitro to blastocyst (see Fig. 1). Parthenogenic
activation was not observed when fresh or warmed oocytes were
cultured in either mT6 and KSOMaa, as described for the in vitro
fertilisation (IVF) experiments. Significantly more oocytes treated
with 0.1 and 0.3 M trehalose survived post-warming recovery than
those treated with 0.2 M trehalose (P,0.05; see Table 1). The 0.1
and 0.3 M trehalose treated oocytes also exhibited recovery rates
similar to non-trehalose treated oocytes. Similarly, a higher
number of 0, 0.1 or 0.3 M trehalose treated oocytes successfully
underwent IVF and progressed to the 2-cell stage than the 0.2 M
cohort. Again, significantly more 0.1 and 0.3 M treated cohorts
developed to blastocyst (see Fig. 1) than the 0.2 M cohort
(P,0.05). In contrast, blastocyst rates were significantly lower
for the vitrified oocytes when compared with embryos produced
with fresh oocytes (Table 1).
As significantly fewer oocytes from the 0.2 M trehalose cohort
survived post-warming, we determined whether the vitrification
process affected the distribution of mitochondria following
warming. We stained oocytes from each cohort with MitoTracker
Deep Red FM (Fig. 2A–E) and assessed the distribution of
mitochondrial clustering. The clustering was similar for the fresh,
0 and 0.1 M treated groups (Fig. 2A;B;C;F), although for the
0.3 M treatment it was significantly lower (P,0.05; Fig. 2E;F).
The values for the 0.2 M cohort demonstrated very little clustering
relative to the fresh oocyte population (P,0.05; Fig. 2D;F).
We then cultured a cohort (n = 15) of 2-cell embryos from the
0.3 M cohort to the blastocyst stage, to determine whether they
could give rise to viable ESCs (see Fig. 1). Whole blastocyts were
plated onto a monolayer of MEFs to promote their expansion and
to produce colonies of cells that resembled pluripotent ESCs
(Fig. 3A), which were then further passaged to demonstrate their
ability to generate proliferative colonies. In all, 9 lines were
established and one was fully characterised, ViO-ES9. ViO-ES9
was analysed for expression of genes associated with pluripotency.
They were positive for the expression of Oct4, Dppa3, Dppa5 and
Pramel7 but failed to express Nanog (Fig. 3B). Using immunocyto-
chemistry (ICC), we also confirmed that ESC colonies contained a
few isolated areas of positive staining for NANOG but no staining
for OCT4, SSEA-1 or alkaline phosphatase (Fig. 3C). In contrast,
D3 (control) cells exhibited positive staining for NANOG, OCT4,
SSEA-1 and alkaline phosphatase in most cells (Fig. 3C).
Nevertheless, we further tested the pluripotent potential of the
ViO-ES9 cells in vivo by generating teratomas. Undifferentiated cells
were injected into the hind leg of SCID mice and, after 6 weeks,
teratomas were recovered. Heamatoxylin and eosin staining revealed
that they contained tissues indicative of the three germ layers
including secretory epithelium (endoderm), cartilage (mesoderm) and
epidermal tissue (ectoderm) (Fig. 4Ai–iii). The ViO-ES9 cells were
also differentiated using the hanging droplet method to produce
embryoid bodies, which were plated onto culture dishes to promote
further differentiation. The outgrowths showed clear indications of
differentiating cells and they were analysed by RT-PCR and ICC for
markers of each of the 3 germ layers. Colonies were positive for
endoderm (AFP – Fig. 4Bi), ectoderm (Nestin – Fig. 4Biii; Fig. 4C;
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Vimentin – Fig. 4C), and mesoderm (GATA4 – Fig. 4Bii; Flk-1, VE-
Cadherin, PECAM – Fig. 4C).
Close inspection of the in vitro growth patterns within the culture
dish of late passage cells led us to analyse the karyotype of these
cells. This was abnormal (data not shown). Subsequent analysis of
early passage cells revealed the same outcome (Fig. 5). Cells were
commonly trisomies for chromosomes 1, 6 and 11 and contained
an extra Y chromosome.
In order to determine whether the abnormal karyotype resulted
from the vitrification protocol or the in vitro culture environment,
we transferred embryos from fresh and the 0.1 and 0.3 M
trehalose treated cohorts of oocytes to surrogates. Live offspring
were generated from each cohort (see Table 2). Although higher
numbers of blastocysts were obtained following IVF with fresh
oocytes (Table 1), no significant differences were observed for
offspring rates following embryo transfer (Table 2). The vast
majority of these offspring generated from the 0.1 M and 0.3 M
trehalose-treated oocytes (9/10) were karotypically normal
(Fig. 5B). As one of these animals was karyotypically abnormal,
we decided to further test whether vitrification was responsible for
the chromosomal instability. Here, we again used fertilised fresh
and vitrified oocytes from the 0.3 M cohort to produce 2-cell
embryos, which were vitrified and stored for a minimum of one
month (Table 3). Following warming, 2-cell embryos were
transferred to surrogates who gave birth to live offspring
(Table 3). None of the 3 offspring analysed showed any
chromosomal instability (data not shown), although one offspring
was larger than the others at birth and remained so during
adolescence and adulthood. It subsequently died at 7 months
whilst the others appeared healthy up to the age of 12 months at
which point they were humanely killed. Furthermore, in order to
determine whether the offspring derived from oocyte vitrification
had normal reproduction capability, we mated control and 0 and
0.1 M cohort males with C57Bl6/J females. This resulted in the
generation of live offspring at a rate of 6.14, 6.25 and 5.5 offspring
per mating, respectively.
Discussion
Vitrification offers the opportunity for the long-term storage of
oocytes and we have demonstrated the cryoprotective potential of
administering extracellular trehalose on mouse oocytes during
vitrification and warming. Viability was demonstrated by oocyte
post-warming survival, cleavage, pre- and post-implantation
embryo development and through the generation of live offspring.
We have further demonstrated that two-cell embryos from vitrified
oocytes can successfully undergo a further round of vitrification
and subsequent warming and give rise to live offspring. These
offspring appeared to have normal reproductive function as they
produced viable offspring. However, vitrified oocytes that are
warmed, fertilised and then cultured to the final stages of
preimplantation development had a tendency to genetic instability
as demonstrated by the chromosomal aberrations observed in the
ES cells derived from their blastocysts.
There is a substantial body of evidence to suggest that
temperature [23] and osmotic changes [24] during the freezing
and thawing process can damage the structural integrity of cells.
Oocyte cryopreservation has also been reported to damage the
mitotic spindle [14], harden the zona pellucida [13] and to
promote oocyte activation, which leads to parthenogenesis [12].
The osmolyte, trehalose, has been used to protect mammalian
cells, gametes and embryos following freezing or storage in the dry
state. Addition of trehalose to a cryoprotective solution signifi-
cantly improved the colony forming units of haemotopoeitic cells
following thawing and culture [25]. Similarly, extracellular
trehalose has been reported to either maintain or increase the
post-thaw motility of boar [26], bovine [27] and ram sperm [28].
Mouse embryo viability was reported to be double when frozen in
the presence of trehalose rather than in its absence [29].
Furthermore, Guo et al. showed that human primary fibroblasts,
which were engineered to produce this saccharide, were viable
following rehydration after storage of up to five days at the dry
stage. Likewise, mouse [30] and rhesus macaque [31] sperm have
been reported to promote fertilisation and embryo development
following ICSI.
In our work, the post-warming survival rates were not
significantly different when oocytes were vitrified in 0 (85.4%),
0.1 (82%) or 0.3 M (85.9%) trehalose but survival was significantly
Figure 1. Following in vitro fertilization and culture, both fresh
(A1) and vitrified oocytes in 0.1 M trehalose (B1) were capable
of developing to the two-cell (A2; B2), four-cell (A3; B3) and
blastocyst (A4; B4) stages, respectively. Furthermore, blastocysts
were able to hatch (A5; B5) without chemical or mechanical assistance
and some were used to derive embryonic stem cells.
doi:10.1371/journal.pone.0021597.g001
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lower when vitrified in the 0.2 M solution (37.2%). Trehalose is
understood to be a non-toxic osmolyte and the non-linear dose
response of oocytes to 0.2 M solution observed in our studies was
not expected. Consequently, we assessed mitochondrial clustering
in each of the cohorts at this stage where we know from previous
work that mitochondrial content in oocytes is a key criterion
associated with developmental competency [16,32,33]. We report
here that the addition of 0.1 M trehalose to the CPA improves the
distribution of mitochondrial clustering, but 0.2 M trehalose has a
harmful effect as evidenced by poor clustering and the increased
presence of cytoplasmic-like vacuoles (cf Fig. 2A,B,C and D).
However, increasing the trehalose concentration to 0.3 M
appeared to partially restore mitochondrial clustering (Fig. 2E).
These outcomes suggest an ‘all or none’ effect whereby the lower
0.1 M trehalose concentration is sufficiently low not to be harmful
to mitochondria, but 0.3 M is present in sufficient abundance to
have a protective effect. Consequently, the 0.2 M trehalose
concentration appears to negate this protective effect.
Mitochondria are sensitive organelles with their viability
dependent on a high mitochondrial membrane potential. Indeed,
mitochondrial dysfunction in the oocyte is responsible for the early
arrest of preimplantation embryos in vitro [34] and when mediated
through disruption to the mitochondrial membrane potential can
result in apoptosis [35], which would account for some of the
embryo loss during preimplantation development. Furthermore,
the failure of metaphase II oocytes to establish mitochondrial
developmental competency, and then supplemented with diver-
gent populations of mitochondria, can result in a series of
disorders, such as pervasive development disorder, and genetic
instability as evidenced by Turner’s (XO) syndrome [36] and
hence the genomic instability we observe in our ESCs.
Cleavage rates for our vitrified oocytes (50–74.4%) following
IVF were not significantly different to the control IVF cohort
(76.4%). Similar cleavage rates have been reported for oocytes
cryopreserved in the presence of 0.5 extracellular trehalose (63%;
[8]), or when slowly frozen using a non-programmable freezer in a
CJ2 solution containing 18% fetal bovine serum, 1.5 M propane-
diol and 0.1 M sucrose, and following laser ablation of the zona
pellucida prior to IVF (48%; [9]) but lower than those when
trehalose was microinjected into the oocyte prior to cryopreser-
vation (83%; [8]). Nevertheless, following warming, sperm were
capable of penetrating the zona pellucida of our vitrified oocytes,
fertilisation and promoting embryo development to the hatched
stage without having to perform ICSI or zona laser ablation. Our
developmental rates (number of blastocysts per two-cell stage
embryo) were 52.4, 80.5, 29.4 and 78.0% from oocytes vitrified in
the presence of 0 M, 0.1 M, 0.2 M and 0.3 M trehalose,
respectively.
Following embryo transfer, there were no significant differences
in offspring survival rates between non-vitrified and 0.1 M
trehalose vitrified oocytes (20% v 27.3%). However, oocytes
vitrified in 0 or 0.3 M trehalose resulted in 13% and 10% live
offspring, respectively. These rates are similar to those reported for
oocytes cryopreserved by slow cooling with intra- and extracellular
trehalose [8]. Following IVF and embryo transfer, these workers
reported the birth of five pups (23%) from non-cryopreserved
control oocytes and 4 (19%) from cryopreserved oocytes when
embryos were transferred at the two-cell stage. Similar results were
reported by these workers when they transferred blastocysts from
unfrozen (7 pups; 28%) and frozen oocytes (3 pups; 14%) into
surrogates. In contrast, live offspring rates of 26.7% and 46.7%
have been reported from oocytes cryopreserved in a choline based
solution with 1.5 M 1,2-propanediol and 0.1 M sucrose, and using
a programmable or non-programmable freezer, respectively and
subjected to laser ablation of the zona pellucida prior to IVF [9].
Nevertheless, the live offspring generated from trehalose-vitrified
oocytes maintained genetic stability as evidenced by their normal
karyotypes.
Our data would clearly suggest that there is a developmental
advantage for fertilised vitrified oocytes being transferred at the 2-
cell rather than the blastocyst stage. The chromosomal aberrations
that we observed in early and later passage ESCs were most likely
the result of in vitro culture to the blastocyst stage followed by ESC
derivation. This also seemed to affect their ability to maintain
pluripotent gene expression although they produced teratomas
and representative gene expression of markers of differentiation. It
is thus highly likely that the uterus of the surrogate mouse offers
considerable metabolic support that the in vitro culture environ-
ment is unable to provide. Indeed, in vitro culture can result in a
variety of genetic and epigenetic abnormalities [37]. Similar
outcomes arise from poor diet prior to conception and during
pregnancy, which affect epigenetic integrity, offspring size and
development rates [38].
Nevertheless, it is likely that the inter-uterine environment of
healthy and reproductive competent mice will be better able to
sustain and support the metabolic function of these embryos
during early development and until the embryonic genome takes
over [39] and mitochondrial replication is initiated at the
blastocyst stage [16]. Consequently, key molecular events such
as cytokinesis, karyokinesis and de novo methylation can be
appropriately metabolically supported. The current in vitro
culture systems are likely to be unable to provide this degree of
metabolic support. This is further substantiated by the generation
of live offspring from the vitrification of 2-cell embryos generated
from vitrified oocytes, that were able to, on the whole, maintain
genetic integrity and give rise to live offspring. This, to the best of
Table 1. Survival, two-cell and blastocyst rates for vitrified mouse oocytes following IVF.
Treatment
(M of Trehalose) Vitrified Oocytes
Post-warming survival
(%) Oocytes in culture post IVF (%)
Two-cell
(%) Blastocyst (%)
Fresh 110 (not vitrified) N/A 105 (95.5) 84 (76.4) 82 (74.5)**
0 82 70 (85.4) 64 (78.0) 61 (74.4) 32 (39.0)
0.1 139 114 (82.0) 89 (64.0) 77 (55.4) 62 (44.6)
0.2 85 32 (37.2)* 25 (29.4)* 17 (20.0)* 5 (5.9)*
0.3 99 85 (85.9) 63 (63.6) 50 (50.5) 39 (39.4)
*Fisher’s test significantly lower than other treatments (P,0.05);
**Fisher’s test significantly higher than other treatments within the same column (P,0.001). IVF Data collected from 3 replicates.
doi:10.1371/journal.pone.0021597.t001
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our knowledge, is the first report of such an outcome and should
eliminate any concerns that vitrification may raise for subsequent
offspring survival. However, endeavours to generate pluripotent
embryonic stem cells from vitrified oocytes to provide multiple
genetically identical donors for nuclear transfer will require refined
culture systems to ensure that genetic abnormalities can be
avoided and that these cells offer a viable approach to rescue
endangered species.
A further concern regarding vitrification has been the potential for
cross-contamination. Vitrification of oocytes and embryos is
traditionally carried out in open systems such as open pulled straws
[40], electron microscope grids [41], cryoloop [42], solid-surface
vitrification [43] or nylon mesh [44]. The use of these systems
subjects the oocytes or embryos to direct contact with liquid nitrogen
and to the risk of contamination as it is widely acknowledged that
viral and bacterial pathogenic agents survive in liquid nitrogen [45].
Figure 2. Assessment of mitochondrial integrity in fresh (A) or vitrified mouse oocytes in the presence of 0 (B), 0.1 (C), 0.2 (D) or 0.3
(E) trehalose labelled with Deep MitoTracker Red. Nuclei were stained with DAPI. The level of clustering of mitochondria (F) at the distance
criterion (r) of 5 mm, displayed as mean6 SEM. Treatment groups that were significantly different (p,0.05) to that of Fresh oocytes are denoted by *.
doi:10.1371/journal.pone.0021597.g002
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Bielanski et al [46] observed that, when samples are stored in sealed
straws or closed cryovials, the risk of pathogen contamination during
vitrification and storage of samples in liquid nitrogen is removed.
They reported that, when samples were stored in unsealed
containers, the incidence of viral contamination due to exposure to
contaminated liquid nitrogen was 22% whilst no contamination was
observed in samples stored in closed containers. Therefore, the
method presented here reduces this risk, as straws are sealed with a
metal sealing ball before vitrification is carried out. Indeed, use of the
method presented here together with the use of sterilised liquid
nitrogen either by UV exposure [47] and storage in vapour phase
tanks [48] will assist in avoiding the risk of pathogen cross-
contamination during sample storage.
In conclusion, we have shown that oocytes can be successfully
vitrified using a combination of trehalose and sucrose based CPAs
and that successful vitrification using trehalose is concentration-
dependent. The use of 0.1 and 0.3 M trehalose provides the
oocyte with mitochondrial protection and ensures that, when
embryos are transferred at early stages of development, live
offspring can be successfully produced. Furthermore, this form of
oocyte storage can be used as part of a ‘closed’ vitrification system
and will prevent cross-contamination.
Materials and Methods
Experimental procedures were approved by the Monash
Medical Centre Animal Ethics Committee for animal experimen-
tation and were conducted in accordance with the Australian
National Health and Medical Research Council (NHMRC)
guidelines. Approval numbers were MMCA 2007/1 and MMCA
2007/39.
Mice
F1 hybrid mice (C57Bl6CBA) were used for the present study.
Mice were kept under constant environmental conditions of
12L:12D and a temperature of 25uC.
Media
All media were prepared from analytical grade chemicals (BDH
Chemicals Pty., Ltd., Melbourne, Australia or Sigma-Aldrich Co.,
St. Louis, MO). Oocytes were collected in modified KSOM-
HEPES and cultured in modified KSOMaa [49]. Embryos were
also cultured in modified KSOMaa. Sperm were collected and
capacitated in modified Tyrode’s medium (mT6; [50,51]) without
sodium pyruvate or sodium lactate.
Oocyte collection
Six-week-old females were superovulated by an intraperitoneal
injection of 5 IU equine chorionic gona-dotrophin (Folligon,
Intervet International, Boxmeer, The Netherlands) followed by
5 IU hCG (Chorulon, Intervet International) in 0.2 ml saline 48 h
later. At 13 to 14 h after hCG injection, oocyte-cumulus complexes
were collected from the oviducts into KSOM-HEPES containing
60 IU/ml hyaluronidase (Sigma type IV-S) for 5 min. Adhering
cumulus cells were removed from oocytes by gentle pipetting and
Figure 3. Expression of pluripotent markers in ViO-ES9 cells: ES cell colonies derived from vitrified oocytes (A). RT-PCR amplification
of Oct4, Dppa3, Dppa5, Pramel7 and Nanog in ViO-ES9 cells at passage (P) 5 and 7 (B); ViO-ES9 and D3-ES cells were stained with antibodies to OCT-4,
SOX-2, SSEA-1 and with alkaline phosphatase. Nuclei are stained with DAPI (blue) (C).
doi:10.1371/journal.pone.0021597.g003
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Figure 4. Histology and Hematoxylin and Eosin staining of teratoma tissue from ViO-ES9 cells showing differentiation into tissues
indicative of the three germ layers (A) including secretory epithelium (i), articular cartilage (ii) and keratinized epithelium (iii).
Immunoflorescent analysis of differentiation into all three germ layers (B): AFP (i); GATA-4 (ii); and NESTIN (iii). Secondary antibodies were labelled
with Alexa FluroH 488 (green) except for GATA-4 which was labelled with Alexa FluroH 594 (red). Nuclei are stained with DAPI (blue). RT-PCR for Flk-1,
VE-Cadherin, PECAM, Vimentin and Nestin (C).
doi:10.1371/journal.pone.0021597.g004
Figure 5. Karyotype analysis of ES cells and live offspring derived from vitrified oocytes. A) Karyotype analysis performed on ViO-ES9
cells revealed a number of abnormalities. The male cell line has a chromosome count of 46. B) Karyotype analysis performed on the mice that were
generated from vitrified oocytes revealed normal karyotypes, a representative karyotype for one of the male mice shows a normal 40 XY
chromosome count with no abnormalities.
doi:10.1371/journal.pone.0021597.g005
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washed in KSOM-HEPES. Oocytes were then placed into 20 ml
drops of modified KSOMaa previously equilibrated under mineral
oil in 5% CO2 in air at 37uC for at least 30 min before they were
vitrified or placed into a 90 ml drop of mT6 under oil in 5% CO2 in
air for 30 min before IVF was carried out.
Oocyte/Embryo Vitrification and Warming
Exposure of oocytes and embryos to cryoprotectants was carried
out on the microscope stage set to 37uC. Cohorts of oocytes or
two-cell embryos (5–10), as indicated, were placed into 20 mL
drops of KSOM-Hepes containing 8% DMSO (1.4 M) and 8%
(1.4 M) ethylene glycol for 1 min at 37uC. Oocytes and two-cell
embryos were then transferred to KSOM-HEPES containing 16%
DMSO (2.8 M) and 16% ethylene glycol (2.8 M), 10 mg/ml
Ficoll, 0.65 M sucrose with 0, 0.1, 0.2 or 0.3 M trehalose for 20 s
at 37uC. Oocytes were then loaded into 0.25 ml straws sealed with
a metal sealing ball (Minitube, Smythesdale, VIC, Australia) slowly
pressed against a metal block (Cryologic Vitrification block CVM);
Cryologic, Mulgrave, VIC, Australia) for 30–45 s and then
transferred into liquid nitrogen and stored for at least a week in
a liquid nitrogen vapour phase tank.
Warming
Straws were removed from the storage tank and transferred into
a container with liquid nitrogen. Before warming, straws were held
for 30–40 sec in the vapour phase of liquid nitrogen, held in the
air for 5 sec then transferred into a water bath at 37uC. The straws
were then dried, the sealing ball removed and the oocytes expelled
into a 20 ml drop of KSOM-Hepes containing 0.25 M sucrose at
37uC for 2 min. The oocytes were then transferred to a 20 ml drop
of KSOM-Hepes containing 0.125 M sucrose at 37uC for a
further 3 min, then into KSOM-Hepes at 37uC for 5 min and
finally into a 90 ml drop of mT6 under oil in 5% CO2 in air for
30 min before IVF was carried out.
Oocyte imaging
MitoTracker Deep Red FM (Invitrogen) was used to visualize
oocyte mitochondria. Zona pellucidae were first removed by
incubation in an acidified Tyrode’s solution for 3–5 minutes [52].
After recovery, zona-free oocytes were incubated in KSOM-Hepes
containing 100 nM of Mitotracker Deep Red for 45 min. Oocytes
were then washed twice with PBS containing 0.05% (v/v) Tween-
20 (PBS-T) and fixed in 2% (w/v) paraformaldehyde in PBS-T.
Following fixation, zona-free oocytes were transferred to an 8-well
slide (Ibidi) for analysis with a Nikon C1 laser scanning confocal
microscope on a Nikon Ti-E inverted microscope base. 6061.4NA
objective was used to image samples. 633 nm laser was used to
specifically excite MitoTracker Deep Red and the fluorescence
emission was detected via a 645/75 nm filter.
Ripley’s clustering analysis
Ripley’s K-function, for three-dimensional data, weighted by
the intensity of point:
K rð Þ~ V
S2
XN
i~1
Int ið Þ
XN
j~1
Int jð Þc i,j,rð Þ
The intensity of a data point x (given by Int(x)) was considered to
be the assumed (relative) number of actual agents (or points) in that
position. V is the volume of the domain, N is the number of data
points, and S is the sum of all intensities: ~
PN
i~1 Int ið Þ, i.e: the
total number of assumed agents. c(i,j,r) is an indicator function,
which obtains the value = 1 if the distance between the i’th and j’th
points is less or equal to r, and= 0 otherwise.
For a data set in a three dimensional space, the benchmark
obtained by a homogeneous Poisson process is: 4
3
pr3. Values
significantly different to it will indicate the points are not
distributed homogenously, i.e. the points are spatially clustered.
In order to avoid underestimation of K due to edge effects we
introduced a buffer zone, so that the first sum would only go over
points for which the distance from any of the domain’s boundaries
was larger or equal to the largest value of r.
In vitro fertilization (IVF)
Sperm were collected from 10 to 12-week-old males. Briefly,
both caudae epididymides were dissected from the mice and a
Table 2. Survival, and live offspring rates for vitrified oocytes.
Treatment
(M of Trehalose)
Vitrified
Oocytes Post-warming survival
Two-cell
(%) Transferred Pups (%)
Fresh 20 (not vitrified) N/A 14 (70.0) 14 4 (20)
0 49 39 (79.6) 29 (59.2) 23 (46.9) 3 (13.0)
0.1 52 37 (71.2) 31 (59.6) 22 (42.3) 6 (27.3)
0.3 48 35 (72.9) 25 (52.1) 10 (37.5) 1 (10.0)
Fisher’s test indicated no significant differences between the treatments within same column (P.0.05). Oocyte and live offspring data collected from 5 and 2 replicates
respectively.
doi:10.1371/journal.pone.0021597.t002
Table 3. Survival, vitrified two-cell embryo and live offspring rates from either fresh or vitrified oocytes.
Treatment Vitrified embryos two-cell stage Post-warming survival Transferred Pups (%)
Fresh (not vitrified) 47 22 (46.8) 16 (72.7) 6 (37.5)
0.3 M Trehalose 27 13 (48.1) 8 (61.5) 3 (37.5)
Fisher’s test indicated no significant differences between the treatments within same column (P.0.05).
doi:10.1371/journal.pone.0021597.t003
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small slit was made in each cauda before transfer to 1 ml modified
mT6 and equilibrated in 5% CO2 in air at 37uC in a 5 ml
(NUNC, Roskilde, Denmark) under oil. The epididymal tissue was
then removed from the tube 1 h later, and the sperm
concentration was assessed and adjusted to 3 to 56106 sperm/
ml and a 10 ml aliquot was added to the oocytes. Sperm and
oocytes were incubated for 6 h, under mineral oil. Oocytes were
then removed from the sperm solution, washed in KSOM-Hepes,
and cultured at 37uC in modified KSOMaa under mineral oil in
5% CO2 in air. Six hours later, oocytes were examined for signs of
normal fertilization. Oocytes with two pronuclei and a second
polar body were regarded as fertilized. These oocytes were
separated from unfertilized oocytes and cultured in modified
KSOMaa at 37uC under 5% CO in air up to 96 h for
development to the blastocyst stage.
Parthenogenic activation
Twenty to twenty five freshly collected MII oocytes and vitrified
oocytes per cohort were thawed and transferred into a 90 ml drop
of modified Tyrode’s medium under oil in 5% CO2 in air for 6 h
without sperm and cultured in modified KSOMaa at 37uC under
5% CO2 in air for up to 96 h.
Embryo transfers
Two-cell embryos produced following IVF were transferred to
the oviducts of Day 1 pseudopregnant F1 females mated to
vasectomized F1 males of proven sterility. Between 8 and 12
embryos were transferred to each oviduct. Females were allowed
to give birth and the number of pups on the day of birth was
recorded.
Natural mating
Two males from the breeding colony (control) and from the 0
and 0.1 cohorts, were bred for two cycles with C57Bl6/J six week
old females and the number of live offspring per male/treatment
recorded.
Culture and preparation of feeder layers
Murine embryonic fibroblasts (MEFS) were cultured in High
Glucose Dulbecco’s Modified Eagle’s Medium (DMEM; Sigma,
Gillingham, UK) with 10% fetal bovine serum (FBS; Sigma),
2 mM L-glutamine (Invitrogen Life Technologies, Paisley, UK),
1% non-essential amino acids (NEAA; Invitrogen Life Technol-
ogies) and 1% penicillin/streptomycin solution (Sigma). MEFs
were inactivated using mitomycin C (Sigma; 10 mg/ml) for
2 hours at 37uC/5% CO2, and then washed 3 times with PBS
(Sigma) and cultured overnight or frozen before use as feeder cells
for undifferentiated mES cells.
Derivation of mES cells
Expanded blastocysts were cultured until they hatched. They
were then transferred to 96-well plates containing MEFS and
blastocyst culture media and allowed to expand. Once an
expanding colony had been identified, the cells were cultured as
for D3 mES cells. They were manually passaged onto 48-, 24- and
6-well plates (BD Falcon, North Ryde, NSW, Australia) containing
MEFS, and once established, onto Petri-dishes (BD Falcon).
Culture of mES cells
D3 mES cells and ViO- ViO-ES9s were cultured, as described
in [53]. Briefly they were placed in High Glucose DMEM (Sigma)
with 15% ES cell screened fetal bovine serum (FBS; Hyclone,
Utah, US), 1% penicillin/streptomycin solution (Invitrogen Life
Technologies), 2 mM L-glutamine (Invitrogen Life Technologies),
1% NEAA (Invitrogen Life Technologies), 0.1 mM b-mercapto-
ethanol (Sigma) and 1000 U/ml LIF.
Differentiation of mESCs
Undifferentiated ViO-ES9 and D3 mES cells were induced to
differentiate using the hanging drop method [54]. Briefly, mES
cells (Day 0) were dissociated with 0.25% trypsin-EDTA (Sigma)
for 2 minutes, resuspended into mES cell media and plated as
20 ml droplets (approximately 450 cells per drop) on the lid of an
inverted Petri dish (Sterilin, Staffordshire, UK) for 48 hours (Days
1 to 2) to promote the formation of EBs. The EBs were then placed
into suspension for a further 5 (Days 3 to 7, D3 mES cells) or 6
days (Days 3 to 8, R1 mESCs) at 37uC/5%CO2. The EBs were
then plated onto gelatin (0.1%; Sigma) coated 6 well plates (Nunc,
Roskilde, Denmark) and cultured up to Day 20 of differentiation.
RNA isolation
RNA was extracted from cells and contaminating DNA
eliminated using the RNAqueousH-4PCR Kit (Applera, Warring-
ton, U.K., http://www.appliedbiosystems.com) according to the
manufacturer’s protocol for mammalian cells.
Reverse Transcription
cDNA was produced using the BioscriptTM system (Bioline,
London, U.K., http://www.bioline.com) according to the manu-
facturer’s protocol. Each reaction contained 5 mg RNA and 200 U
of reverse transcriptase. The reaction was performed at 42uC for
1 h in a MJ Research PTC-200 thermocycler (GRI, Braintree,
UK).
PCR analysis
PCR was performed in 50 ml reactions containing 200 ng of
cDNA, 16 PCR buffer (Bioline, London, UK), 1.5 mM MgCl2
(Bioline), 100 mM dNTPs (Bioline), 0.5 mM for each of the forward
and reverse primers (Gapdh: GGGAAGCCCATCACCAT-
CTTC and AGAGGGGCCATCCACAGTCT to produce
366 bp; Oct4: AGTATGAGGCTACAGGGACA and CAAA-
GCTCCAGGTTCTCTTG - 260 bp; Dppa3: CTTTCCCAA-
GAGAAGGGTCC and TGCAGAGACATCTGAATGGC -
149 bp; Dppa5: GCTTGATCTCGTCTTCCCTG and TCCA-
TTTAGCCCGAATCTTG - 293 bp; Pramel7: AGAGAACC-
CACATGGCTTTG and GGATTTGGCTTGGCATACAT -
336 bp; Nanog: AGGGTCTGCTACTGAGATGCTCTG and
CAACCACTGGTTTTTCTGCCACCG - 364 bp; Flk-1: TC-
TGTGGTTCTGCGTGGAGA and GTATCATTTCCAACC-
ACCCT - 270 bp; CD31: 59-CGCACCTTGATCTTCCT-
TTC and AAGGCGAGGAGGGTTAGGTA - 244 bp; and
VE-cadherin: TCCTCTGCATCCTCACCATCACA and GTAA-
GTGACCAACTGCTCGTGAAT - 122 bp and 2.5 U BioTaq
DNA polymerase (Bioline). Reactions were run on a MJ Research
PTC-200 machine: initial denaturation at 95uC for 5 min;
followed by 35 cycles of 94uC for 30 sec (except for Gapdh 25
cycles); annealing at 60uC for 45 sec (Gapdh; Flk-1), 55uC for
30 sec (Oct4), 57uC for 30 secs (VE-Cadherin), 60uC for 30 sec
(Dppa3), 60uC for 30 sec (Dppa5), 60uC for 45 sec (Pramel7), and
62uC for 20 sec (Nanog); 72uC for 45 sec; and a final extension at
72uC for 3 min. PCR products were resolved on 2% agarose gels
(Bioline) at 100 V for 1 h.
Karyotype analysis
Karyotype analyses of both mice and ES cells were performed
by Southern Cross Pathology, Australia. In brief, for mice primary
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tail tip fibroblasts were isolated following mechanical dissection
and incubated in trypsin for 7 minutes and cultured in MEF
media until cell explants were observed. ES cells in their
exponential growth phase were analysed.
Teratoma generation
To examine teratoma formation, 1–26106 cells were injected
into the rear leg muscle of 4–6 week old severe combined
immunodeficient (SCID) mice. After 4 weeks, the teratomas were
excised and fixed in 4% paraformaldehyde, embeded in paraffin,
sectioned at 5 uM and stained with Hematoxylin and Eosin using
standard methods performed by the Monash Institute of Medical
Research Histology Core Facility.
Statistical analyses
Survival, embryo development and offspring data were
subjected to contingency tables and Fisher’s exact test. For oocyte
volume and mitochondrial clustering measurements, the means of
each group were tested against the control (Fresh oocytes) by One-
Way ANOVA test with Dunnett’s Multiple Comparison post-test.
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